Zobrazeno 1 - 10
of 7 147
pro vyhledávání: '"Recombinant Human Erythropoietin"'
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 18, Iss 1, Pp 1-9 (2023)
Abstract Background Postoperative anemia is a risk factor for adverse surgical outcomes. Our study aimed to assess the role of intravenous iron and erythropoietin therapy for the rapid correction of anemia following orthopedic surgery. Methods Patien
Externí odkaz:
https://doaj.org/article/368041105d60450abd6839c820d72bbd
Publikováno v:
Asian Journal of Medical Sciences, Vol 13, Iss 12, Pp 131-137 (2022)
Background: Iron deficiency anemia continues to be a serious problem in developing countries resulting in spectrum of adverse events in pregnant women. The first choice for prophylaxis and treatment of mild IDA in pregnancy is oral iron therapy. Howe
Externí odkaz:
https://doaj.org/article/8c2c55a6142541269f393a9f37b71554
Publikováno v:
Journal of Nephropathology, Vol 12, Iss 4, Pp e17238-e17238 (2023)
Introduction: Patients with chronic kidney disease (CKD) have increasingly been diagnosed with cognitive impairment. Glycogen synthase kinase 3β (GSK3β) is directly causing both phosphorylated tau (pTau) and amyloid β (Aβ) accumulation in Alzheim
Externí odkaz:
https://doaj.org/article/29684b4bc862419eb5a4b846517d77fd
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shuiqin Cheng, Tingting Zhou, Le Yu, Zhihong Zhang, Yunmin Chen, Man Zhang, Jingjing Cui, Wenxin Yu, Jian Zhou, Yusheng Yu
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionRoxadustat treatment in PD patients is equivalent to ESAs in increasing hemoglobin (Hb). But blood pressure, cardiovascular parameters, cardio-cerebrovascular complications and prognosis in the two groups before and after treatment has no
Externí odkaz:
https://doaj.org/article/ef74744477e44162ae59e4a043ff7abf
Autor:
Nan Chen, Changying Xing, Jianying Niu, Bicheng Liu, Junzhou Fu, Jiuyang Zhao, Zhaohui Ni, Mei Wang, Wenhu Liu, Jinghong Zhao, Ling Zhong, Xiongfei Wu, Wenge Li, Yuqing Chen, Wei Shi, Jianghua Chen, Aiping Yin, Ping Fu, Rong Wang, Gengru Jiang, Fanfan Hou, Guohua Ding, Jing Chen, Gang Xu, Yuichiro Kondo, Yuliang Su, Changlin Mei
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 8, Iss 1, Pp 59-70 (2022)
Abstract Background Erythropoietin is a glycoprotein that mainly regulates erythropoiesis. In patients with chronic renal failure with anemia, darbepoetin alfa can stimulate erythropoiesis, correct anemia, and maintain hemoglobin levels. This study w
Externí odkaz:
https://doaj.org/article/619f7572badf434a88e30a58ac5ab3c7
Publikováno v:
BMC Musculoskeletal Disorders, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Purpose To find the best short-term daily recombinant human erythropoietin (rhEPO)-based treatment protocols for blood-saving purpose in THA. Method The patients were randomized to 1 of 3 interventions: Patients in group A received 10,000 IU
Externí odkaz:
https://doaj.org/article/d6664d29ef6a4388ab26c0bfee30d411
Autor:
Fatemeh EmamiPari, Soroush Kamali, Ghazaleh Nikzad, Narges Roosta Navi, Sanaz Soltani, Mohamad Reza Kalani
Publikováno v:
Journal of Clinical and Basic Research, Vol 6, Iss 1, Pp 11-27 (2022)
Coronavirus disease 2019 (COVID-19) is a severe acute respiratory disease with a high prevalence. According to the research and statistical data, in January 2021, there have been 92,262,621 confirmed cases of COVID-19 and more than two million deaths
Externí odkaz:
https://doaj.org/article/dccdad05bd384d659434f9e94e16970d